In addition, it addresses the FDA’s communications With all the applicant, the retention of information that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of the SE report back to a completely new applicant and Digital submission in the S